EXC

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN
THE UNITED STATES


Essex Angel Capital Inc. (TSX VENTURE:EXC) (the "Corporation") is pleased to
announce a non-brokered private placement (the "Private Placement") of up to
9,090,910 common shares in the capital of the Corporation (the "Common Shares")
at a price of $0.11 per share for gross proceeds of up to $1,000,000. The Common
Shares will be subject to a four month hold period in accordance with applicable
Canadian securities laws. The Private Placement is subject to the approval of
the TSX Venture Exchange. The net proceeds of the Private Placement will be used
to identify, evaluate and fund investments and for working capital and general
corporate purposes. The Private Placement is scheduled to close on or about
November 30, 2011.


Corporate officers of Essex Angel Capital Inc. will be making individual
investments in the Private Placement. Richard Galdi, Chief Executive Officer,
and Michael Labiak, Chief Operations Officer, will be purchasing 100,000 shares
each, and Julian Hawkins, Chief Financial Officer, will be purchasing 50,000
shares. "This is a strategic time to invest in early stage companies. An
investment in Essex allows investors exposure to private equity investments in
early stage high growth companies, while affording investors the liquidity of
common stock traded daily on an international stock exchange," stated Richard
Galdi, CEO, Essex Angel Capital Inc. 


The proposed purchases of Common Shares by Messrs. Galdi, Labiak and Hawking are
related party transactions pursuant to Multilateral Instrument 61-101,
Protection of Minority Holder in Special Transactions ("MI 61-101") and are
exempt from the formal valuation and minority approval requirements of MI 61-101
pursuant to subsections 5.5(b) and 5.7(b) of MI 61-101.


The Corporation is also pleased to announce that it committed to purchase one
unit (the "Unit") of Wellness Indicators, Inc. ("Wellness"). The Unit consists
of US$200,000 principal amount of 6.0% subordinated secured debentures (the
"Debentures") and 40,000 warrants entitling the Corporation, for seven years
following the issuance date thereof, 40,000 common shares of Wellness at a price
of US$5.00 per share. "We proudly support and look forward to the commercial
product launch of the Wellness Indicators Health Equater(TM) Assessment Profile
in first quarter, 2012", said Galdi. 


The purchase by the Corporation of the Debentures will add to its existing
holdings in Wellness consisting of US$1,000,000 aggregate amount of 6.0%
subordinated secured convertible debentures, convertible in whole or in part,
into common shares of Wellness (the "Wellness Shares") at a conversion price of
US$3.25 per share and warrants entitling the Corporation to acquire 170,221
Wellness Shares at a price of US$3.25 per share.


This news release does not constitute an offer to sell or solicitation of an
offer to sell any of the Common Shares in the United States. The Common Shares
have not been and will not be registered under the United States Securities Act
of 1933, as amended (the "U.S. Securities Act") or any state securities laws and
may not be offered or sold within the United States or to a U.S. Person unless
registered under the U.S. Securities Act and applicable state securities laws or
an exemption from such registration is available. 


This press release contains certain forward-looking statements about the
Corporation's future plans and intentions. Wherever possible, words such as
"may", "will", "should", "could", "expect", "plan", "intend", "anticipate",
"believe", "estimate", "predict" or "potential" or the negative or other
variations of these words, or similar words or phrases, have been used to
identify these forward-looking statements. These statements reflect Management's
current beliefs and are based on information currently available to management
as at the date hereof. Forward-looking statements included or incorporated by
reference in this press release include statements with respect to proposed
terms of, and the intended use of proceeds of, the Private Placement, the
purchase of the Debentures by the Corporation and the proposed purchase of the
Common Shares by Messrs. Galdi, Labiak and Hawkins. 


Forward-looking statements involve significant risk, uncertainties and
assumptions. Many factors could cause actual results, performance or
achievements to differ materially from the results discussed or implied in the
forward-looking statements. These factors should be considered carefully and
readers should not place undue reliance on the forward-looking statements.
Although the forward-looking statements contained in this press release are
based upon what management believes to be reasonable assumptions, the
Corporation cannot assure readers that actual results will be consistent with
these forward-looking statements. These forward-looking statements are made as
of the date of this press release, and the Corporation assumes no obligation to
update or revise them to reflect new events or circumstances, except as required
by law.

Essex Angel Capital Inc. (TSXV:EXC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Essex Angel Capital Inc. (TSXV:EXC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024